Effects of interleukin-1 antagonism on cortisol levels in individuals with obesity: a randomized clinical trial

BACKGROUND: Anti-inflammatory treatment with interleukin-1 (IL-1) antagonism decreases both cortisol and adrenocorticotropin hormone (ACTH) levels in individuals with obesity in short term. However, it remains unknown whether these effects persist upon prolonged treatment. METHODS: In this double-bl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocr Connect
Autors principals: Ebrahimi, Fahim, Urwyler, Sandrine A, Schuetz, Philipp, Mueller, Beat, Bernasconi, Luca, Neyer, Peter, Donath, Marc Y, Christ-Crain, Mirjam
Format: Artigo
Idioma:Inglês
Publicat: Bioscientifica Ltd 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6547405/
https://ncbi.nlm.nih.gov/pubmed/31042669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-19-0201
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars